CNSP Announces Strategic Pivot to Neurology/Oncology, Launches Asset Search, Names Rami Levin CEO, Exec Team Appointed
CNS Pharmaceuticals, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $5.03
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS